
The policy is a drug-compounding framework, not a supplement pathway, but it changes the regulatory backdrop for peptide products, drug preclusion arguments, and gray-market competition.
Virtually all of the company's mineral amino acid chelates and complexes now bear the BCK mark of certification.
BCK is a recognized member of the Association for Kashrut Organizations and is recognized by all rabbinical associations worldwide.






